GSK’s Withdrawn Blood Cancer Drug Paves Path Back to Market
GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...
GSK hails progress for withdrawn blood cancer drug
UK pharma group posts ‘statistically significant’ trial results for treatment combined with Blenrep pulled in 2022 ...
GSK’s Withdrawn Blood Cancer Drug Reduced Risk of Death in Trial
GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...
Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics
Dominic Walsh, a business reporter who previously covered the leisure and drinks industry for The Times from 1997 to 2024, stated in post to X: ...
Seeking Alpha16h
Sanofi: Diverse Drug Portfolio And Future Pipeline, 4% Dividend Yield Looks Attractive
The stock currently offers a 4% dividend yield, while trading below its moving average and with a mixed valuation picture vs ...
MarketWatch18h
GSK falls Wednesday, underperforms market
GSK PLC GSK shares inched down 0.55% to £13.62 Wednesday, on what proved to be an all-around great trading session for the stock market, with the FTSE 100 Index UKX rising 0.06% to 8,030.33. Supported ...
Investing19h
On Holding raised by analysts following Q3 results
Analysts at Williams Trading and BTIG have upgraded their ratings for On Holding AG (ONON) to Buy from Hold/Neutral, ...